Detalles de la búsqueda
1.
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Cancer
; 130(6): 863-875, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788128
2.
Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.
Int J Cancer
; 136(2): 382-91, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24866905
3.
Human papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med
; 363(1): 24-35, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530316
4.
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536941
5.
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
Int J Radiat Oncol Biol Phys
; 116(3): 533-543, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36549347
6.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
J Thorac Oncol
; 18(8): 1055-1069, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146754
7.
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 28(5): 915-927, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911681
8.
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Cancer
; 117(15): 3374-82, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21246525
9.
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
Cancer
; 117(24): 5548-59, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21647871
10.
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect.
Front Oncol
; 10: 566315, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33344227
11.
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Int J Radiat Oncol Biol Phys
; 117(1): 181-185, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019367
12.
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer.
Am J Clin Oncol
; 41(5): 441-446, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27391356
13.
Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer.
Otolaryngol Head Neck Surg
; 137(3): 416-21, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17765768
14.
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 3(4): 483-491, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28006059
15.
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
Int J Radiat Oncol Biol Phys
; 97(4): 687-699, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27727066
16.
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
J Clin Oncol
; 23(10): 2145-54, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15800308
17.
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
Oral Oncol
; 61: 31-40, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27688102
18.
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.
Int J Radiat Oncol Biol Phys
; 95(5): 1346-1354, 2016 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27212198
19.
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer.
J Clin Oncol
; 33(5): 433-41, 2015 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559798
20.
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.
Semin Radiat Oncol
; 12(1 Suppl 1): 34-9, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11917282